Terns Pharmaceuticals Stock Forecast - Rate Of Daily Change

TERN Stock  USD 5.79  0.08  1.40%   
Terns Stock Forecast is based on your current time horizon.
  
Terns Pharmaceuticals has current Rate Of Daily Change of 1.01. Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Terns Pharmaceuticals.
Check Terns Pharmaceuticals VolatilityBacktest Terns PharmaceuticalsInformation Ratio  

Terns Pharmaceuticals Trading Date Momentum

On November 25 2024 Terns Pharmaceuticals was traded for  5.79  at the closing time. The top price for the day was 5.84  and the lowest listed price was  5.54 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 1.38% .
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare Terns Pharmaceuticals to competition

Other Forecasting Options for Terns Pharmaceuticals

For every potential investor in Terns, whether a beginner or expert, Terns Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Terns Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Terns. Basic forecasting techniques help filter out the noise by identifying Terns Pharmaceuticals' price trends.

Terns Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Terns Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Terns Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Terns Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Terns Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Terns Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Terns Pharmaceuticals' current price.

Terns Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Terns Pharmaceuticals stock market strength indicators, traders can identify Terns Pharmaceuticals entry and exit signals to maximize returns.

Terns Pharmaceuticals Risk Indicators

The analysis of Terns Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Terns Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting terns stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Terns Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Terns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Terns Stock

  0.77ME 23Andme HoldingPairCorr

Moving against Terns Stock

  0.71BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.59EWTX Edgewise TherapeuticsPairCorr
  0.59KZR Kezar Life SciencesPairCorr
  0.49GILD Gilead SciencesPairCorr
  0.37KTTAW Pasithea TherapeuticsPairCorr
The ability to find closely correlated positions to Terns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Terns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Terns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Terns Pharmaceuticals to buy it.
The correlation of Terns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Terns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Terns Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Terns Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Terns Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Terns Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections.
To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.18)
Revenue Per Share
0.035
Return On Assets
(0.19)
Return On Equity
(0.28)
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.